Revenue (Quarterly) Chart

View Revenue (Quarterly) for ARHCF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 4.951B
March 31, 2026 4.723B
December 31, 2025 5.409B
September 30, 2025 5.234B
June 30, 2025 5.244B
March 31, 2025 4.585B
December 31, 2024 5.289B
September 30, 2024 4.918B
June 30, 2024 4.636B
March 31, 2024 4.571B
December 31, 2023 5.084B
September 30, 2023 4.972B
June 30, 2023 5.156B
March 31, 2023 4.895B
December 31, 2022 5.060B
September 30, 2022 4.882B
June 30, 2022 5.061B
March 31, 2022 5.333B
December 31, 2021 5.950B
September 30, 2021 5.860B
June 30, 2021 5.883B
March 31, 2021 5.839B
December 31, 2020 6.624B
September 30, 2020 6.094B
June 30, 2020 6.046B
Date Value
March 31, 2020 5.833B
December 31, 2019 6.399B
September 30, 2019 6.429B
June 30, 2019 6.160B
March 31, 2019 5.791B
December 31, 2018 6.250B
September 30, 2018 5.688B
June 30, 2018 6.081B
March 31, 2018 5.800B
December 31, 2017 6.155B
September 30, 2017 5.707B
June 30, 2017 5.820B
March 31, 2017 5.443B
December 31, 2016 6.160B
September 30, 2016 6.001B
June 30, 2016 5.976B
March 31, 2016 5.408B
December 31, 2015 5.693B
September 30, 2015 5.131B
June 30, 2015 5.234B
March 31, 2015 4.985B
December 31, 2014 5.707B
September 30, 2014 5.660B
June 30, 2014 5.735B
March 31, 2014 6.025B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Medipal Holdings Corp. 6.209B
Vital KSK Holdings, Inc. 970.17M
Suzuken Co., Ltd. 3.947B
Cencora, Inc. 84.75B
Cardinal Health, Inc. 63.67B